Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Far East Financials: Two Large Chinese Device Firms Report Mixed Growth

This article was originally published in The Gray Sheet

Executive Summary

China Medical's molecular diagnostic system sales were up 10% in the first quarter to $15.9 million, driven by progress with its fluorescent in situ hybridization probe business, the Beijing company reported Aug. 16

You may also be interested in...



China Medical Technologies Invests $345 Million In HPV Genotyping Chip

China Medical Technologies is acquiring a human papillomavirus genotyping assay which it expects will generate up to $26.5 million in sales next year

J&J And Sanofi Team Up On Phase III E. Coli Vaccine

Sanofi will pay $175m up front for rights to commercialize J&J’s potential first-in-class vaccine against E. coli. The two companies will share profits.

Minute Insight: Medtronic May Sell Respiratory And Monitoring Units To Private Equity

Reuters reported that global private equity firm Carlyle Group has offered to pay at least $7bn for Medtronic’s patient monitoring and respiratory interventions businesses. Medtronic announced its plan to get out of those businesses about one year ago.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT029274

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel